| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC | Director | Class A Common Stock | 188K | $1.18M | $6.29 | Jun 18, 2024 | Direct |
| Alto Neuroscience, Inc. | Director | Stock Option (right to buy) | 30.6K | Feb 1, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IRWD | IRONWOOD PHARMACEUTICALS INC | Jun 18, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
| ANRO | Alto Neuroscience, Inc. | Feb 1, 2024 | 1 | $0 | 4 | Feb 5, 2024 | Director |
| ANRO | Alto Neuroscience, Inc. | Feb 1, 2024 | 0 | $0 | 3 | Feb 1, 2024 | Director |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Jun 20, 2023 | 1 | $0 | 4 | Jun 22, 2023 | Director |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Jun 1, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Dec 15, 2021 | 1 | $0 | 4 | Dec 17, 2021 | Director |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Sep 15, 2021 | 1 | $0 | 4 | Sep 17, 2021 | Director |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Jun 15, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Jun 2, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |